SCHEMBL22087372

SCHEMBL22087372

CC(C)(C)c1cccc(-c2cc3c4cc5ccccc5cc4n4c3c(c2)n2c3ccccc3nc24)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.36
ALDH1A1 P00352 3/20 0.34
LMNA P02545 2/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
PDPK1 O15530 1/20 0.32
TMEM97 Q5BJF2 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
FLT3 P36888 2/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
PTAFR P25105 1/20 0.31
CNR2 P34972 1/20 0.31
ADORA2A P29274 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22088731 0.93 KIF11 (0.36) KIF11ALDH1A1LMNAABCG2KDM4E
SCHEMBL22088867 0.92 ALDH1A1 (0.36) ALDH1A1LMNAKDM4EHPGDFLT3
SCHEMBL22088870 0.89 ADORA2A (0.38) ALDH1A1LMNAKDM4EHPGDADORA2A
SCHEMBL22088844 0.88 ALDH1A1 (0.39) ALDH1A1LMNAKDM4EHPGDADORA2A
SCHEMBL22087373 0.87 MAPT (0.41) ALDH1A1KDM4EHPGDFLT3NPC1
SCHEMBL22088873 0.86 ALDH1A1 (0.42) ALDH1A1LMNAKDM4EHPGDADORA2A
SCHEMBL22062707 0.86 KIF11 (0.42) KIF11ALDH1A1LMNAABCG2KDM4E
SCHEMBL22088253 0.85 ALDH1A1 (0.41) ALDH1A1LMNAKDM4EHPGDFLT3
SCHEMBL22088726 0.85 ALDH1A1 (0.39) ALDH1A1LMNAKDM4EHPGDCNR2
SCHEMBL22087348 0.85 ALDH1A1 (0.41) ALDH1A1LMNAKDM4EHPGDADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181160-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE AHR, EMC2, NFE2L2 KIF11 2195/4885ALDH1A1 2099/4885LMNA 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.